GO
Loading...

Thomson Reuters

More

  • Nov 18- Activist investor Carl Icahn on Monday said there was a chance the stock market could suffer a big decline, saying valuations are rich and earnings at many companies are fueled more by low borrowing costs than management's efforts to boost results.

  • *China reforms help growth currencies; dollar, yen fall. NEW YORK, Nov 18- U.S. stock indices scaled record highs on the prospect of continued Federal Reserve stimulus before mostly retreating on Monday, undermined by a slide in Apple Inc., while bold economic reform plans in China pushed the dollar lower.

  • NEW YORK, Nov 18- U.S. oil prices tumbled on Monday on expectations the Federal Reserve might taper its bond buying program and corn hit a 3- year low after a proposal to lower the use of corn-based ethanol in the United States. Corn weighed the most on the CRB, falling more than 2 percent.

  • *Hong Kong- listed Chinese shares rise 5.7 pct on reform agenda. *China reforms help growth currencies; dollar, yen fall. NEW YORK, Nov 18- U.S. stock indices scaled record highs before retreating on Monday, buoyed by the prospect of continued Federal Reserve stimulus, while the dollar slipped and global equity markets climbed, driven by economic reform plans in China.

  • NEW YORK, Nov 15- Coffee had its biggest gain in more than two years in London, reflecting bad harvesting weather for Vietnam's robusta crop, while cocoa rallied in New York as the "softs" markets dominated Friday's action in commodities. Coffee and cocoa had among the biggest gains of the day on the Thomson Reuters/ Core Commodity CRB index.

  • Nov 15- Cell Therapeutics Inc's shares rose as much as 24 percent after Baxter International Inc threw its financial and marketing heft behind the smaller company's bone marrow disorder drug.

  • The FDA review was posted on the agency's website on Thursday ahead of a meeting of outside advisers to the agency scheduled for Nov. 19. The FDA is not bound to follow the advice of its advisory panels but typically does so. The FDA review said the main safety concerns on Vimizim relate to anaphylaxis and allergic reactions.

  • Nov 15- Baxter International Inc agreed to develop and market Cell Therapeutics Inc's bone marrow disorder drug for payments that could total up to $362 million, sending Cell Therapeutics' shares up more than 30 percent before the bell. Baxter will pay $60 million up front, which includes an equity investment of $30 million in Cell Therapeutics.

  • Twitter introduces self-serve ads outside U.S. Thursday, 14 Nov 2013 | 7:52 PM ET

    SAN FRANCISCO, Nov 14- Twitter Inc said on Thursday it would introduce self-serve ads for small- and medium-sized businesses in three countries outside the United States, marking one of its first moves to expand revenue as a publicly listed company.

  • NEW YORK, Nov 14- The benchmark price of oil rose a second straight day on Thursday on worries about crude supply disruptions in Libya, and gold extended gains as the incoming Federal Reserve chief indicated continued support for the U.S. stimulus.

  • SILVER SPRING, Maryland, Nov 13- A federal advisory panel said safety issues do not preclude approval of Sanofi SA's experimental multiple sclerosis drug Lemtrada on Wednesday, but voiced concerns about the quality of clinical studies.

  • Toll Brothers Inc stands out as the exception. It has also reported a preliminary 6 percent rise in orders, in contrast to the drop in orders just reported by top U.S. homebuilder D.R. Horton Inc and No. 2 PulteGroup Inc. D.R. Horton and PulteGroup cater mainly to first-time buyers or those upgrading to a bigger property for the first time.

  • European shares pare gains on weak euro zone data Thursday, 14 Nov 2013 | 7:18 AM ET

    LONDON, Nov 14- Data showing the euro zone economy slowed sharply in the third quarter curbed a rally in European shares on Thursday, after dovish comments from next Federal Reserve chief Janet Yellen spurred early buying.

  • LONDON, Nov 14- Centrica, one of the big six British utilities under fire from politicians for hiking bills, has cut its 2013 earnings forecast, citing not only rising costs in the UK but also intensifying competition in the United States.

  • Yellen's reassurance helps European shares bounce back Thursday, 14 Nov 2013 | 3:50 AM ET

    LONDON, Nov 14- European shares rallied early on Thursday, recouping all the ground they lost earlier this week, after the Federal Reserve's incoming chair, Janet Yellen, eased concerns that stimulus measures would start to be rolled back this year.

  • *Canada's Saputo waits in wings. SYDNEY, Nov 14- The hotly contested takeover battle for Australia's oldest dairy company got even hotter as its largest shareholder Bega Cheese Ltd raised its bid to $461 million and said it will not attach conditions to its offer like other suitors.

  • SILVER SPRING, Nov 13- A federal advisory panel recommended approval of Sanofi SA's experimental multiple sclerosis drug Lemtrada on Wednesday, but said the drug should be reserved for patients who have failed other therapies. Nathan Fountain of the University of Virginia School of Medicine and the panel's chairperson.

  • NEW YORK, Nov 13- Oil closed higher on Wednesday rebounding from the previous session's loss in reaction to disruptions in exports from Libya, while gold rose to snap a four-day losing streak as investors bought it to hedge against the falling dollar. Copper tumbled to its lowest level in three months after a U.S.

  • SILVER SPRING, Nov 13- A federal advisory panel recommended approval of Sanofi SA's experimental multiple sclerosis drug Lemtrada on Wednesday, but said the drug should be reserved for patients who have failed other therapies. Nathan Fountain of the University of Virginia School of Medicine and the panel's chairperson.

  • ANALYSIS-Contractors squeezed as oil budgets tighten Wednesday, 13 Nov 2013 | 6:15 AM ET

    LONDON, Nov 13- Under pressure from their shareholders to spend less, international oil companies are demanding cheaper and simpler services, equipment and engineering, a red flag for contract firms which rely heavily on their needs. The Thomson Reuters index of 164 global oil services companies is up some 70 percent since 2010..

Most Popular Video

Thursday, 17 Apr 2014 | 3:15 AM ET

Jonny Forsyth, global drinks analyst at Mintel, says China has been a "cash cow" for drink-makers, but the slowdown is having a big impact on sales.

Thursday, 17 Apr 2014 | 1:35 AM ET

CNBC's Helia Ebrahimi discusses the Co-Operative's troubled story from drug buying allegations against the former chairman, to big financial black holes.

Thursday, 17 Apr 2014 | 3:00 AM ET

European shares opened mixed on Thursday, failing to continue a rally on Wall Street after accommodative comments from U.S. Federal Reserve Chair Janet Yellen.